
FDA Okays DHE Nasal Spray for Acute Migraine
The US Food and Drug Administration (FDA) has approved dihydroergotamine (DHE) nasal powder (Atzumi, Satsuma Pharmaceuticals Inc) for the acute treatment of migraine with or without aura in adults Atzumi (previously STS101) is the “first and only” product …